Login
|
Register
News
Videos
Insights
Peer Exchange
OncNurse TV
Resources
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancers
Supportive Care
Hematology
Prevention
Genetics
Nurse Navigation
Immuno-Oncology
Chemotherapy Safety
Skin Cancer/Melanoma
Contributors
Conferences
Partners
Advocacy
Associations
Schools of Nursing
Publications
CE
Nurse's Notes
The New MM: Medical Marijuana
Cover Story
To Test or Not to Test? Pros, Cons, and the Promise of Genomics in Prostate Cancer
From the Chairman
Prostate Cancer Screening Is Controversial
Feature Story
Pursuing a Calling: From Convent to Cancer Care
Fast Facts for the Frontline
The Role of Volunteers in an Oncology Setting
Professionally Speaking
Celebrating Nurses All Year Long
Partner Perspectives
Impact of Goals of Care on Resource Use at End of Life
Adverse Events Report
JAK Inhibition in Myelofibrosis Treatment May Cause Aggressive Lymphoma in Small Percentage of Patients
Clinical Trials in Progress
Glutaminase Inhibitor That Starves Tumor Cells May Improve Survival in Metastatic RCC
Novel RET Inhibitor Tested in Patients With NSCLC, MTC
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources
Newsroom
Continuing Education
Discussions
Web Exclusives
About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.